Myosin light chain kinase (MLCK) is essential for myometrial contractions i
nduced by calcium-mobilizing agonists. From the gene of vertebrate smooth m
uscle/non-muscle MLCK there are at least four proteins expressed. We have f
ound that both a >200 and a 137 kDa MLCK are equally expressed in human non
-pregnant (NP) and term pregnant (P) uterine smooth muscle and confirmed th
at 19 kDa telokin (TK) is only expressed in P myometrium. In addition, we h
ave observed that a MLCK immunogen at similar to 60 kDa is only expressed i
n NP myometrium, suggesting that its expression is inhibited during normal
pregnancy in a hormonally dependent manner. However, when a e compared preg
nant myometrium from patients delivered preterm (PT) (< 34 weeks gestation)
, but not in labour (NIL), with PT patients in labour (IL) we found that PT
(IL) samples expressed the <similar to>60 kDa MLCK immunogen and thus displ
ayed a NP phenotype whereas PT(ML) samples did not express the protein and
retained a pregnant phenotype. We hypothesize that the novel similar to 60
kDa MLCK immunogen contributes to the aberrent contractility associated wit
h preterm labour.